Fondaparinux
Also known as: Arixtra.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 2.5 MG/0.5 ML | Syringe | $20.84 / mL† | — | Generic |
| 5 MG/0.4 ML | Syringe | $55.31 / mL† | — | Generic |
| 7.5 MG/0.6 ML | Syringe | $42.91 / mL† | — | Generic |
| 10 MG/0.8 ML | Syringe | $45.34 / mL† | — | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. † Package size not curated yet — priced per single unit/mL, not per full pen, inhaler, or vial.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $3,054,616 gross for Fondaparinux across 4,104 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$14,736,779 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS